327 related articles for article (PubMed ID: 22227230)
21. Human adenovirus-vectored foot-and-mouth disease vaccines: establishment of a vaccine product profile through in vitro testing.
Brake DA; McIlhaney M; Miller T; Christianson K; Keene A; Lohnas G; Purcell C; Neilan J; Schutta C; Barrera J; Burrage T; Brough DE; Butman BT
Dev Biol (Basel); 2012; 134():123-33. PubMed ID: 22888605
[TBL] [Abstract][Full Text] [Related]
22. Recombinant adenovirus expressing type Asia1 foot-and-mouth disease virus capsid proteins induces protective immunity against homologous virus challenge in mice.
Zhou G; Wang H; Wang F; Yu L
Res Vet Sci; 2013 Jun; 94(3):796-802. PubMed ID: 23267820
[TBL] [Abstract][Full Text] [Related]
23. Immediate protection of swine from foot-and-mouth disease: a combination of adenoviruses expressing interferon alpha and a foot-and-mouth disease virus subunit vaccine.
Moraes MP; Chinsangaram J; Brum MC; Grubman MJ
Vaccine; 2003 Dec; 22(2):268-79. PubMed ID: 14615155
[TBL] [Abstract][Full Text] [Related]
24. Correlation between efficacy and structure of recombinant epitope vaccines against bovine type O foot and mouth disease virus.
Fang M; Li J; Wang H; Yang M; Zhang Y; Zhou L; Wei H; Yang G; Yu Y; Wei X; Yu Y; Wang L; Wan M
Biotechnol Lett; 2012 May; 34(5):839-47. PubMed ID: 22286179
[TBL] [Abstract][Full Text] [Related]
25. Expression of porcine fusion protein IRF7/3(5D) efficiently controls foot-and-mouth disease virus replication.
Ramírez-Carvajal L; Díaz-San Segundo F; Hickman D; Long CR; Zhu J; Rodríguez LL; de los Santos T
J Virol; 2014 Oct; 88(19):11140-53. PubMed ID: 25031341
[TBL] [Abstract][Full Text] [Related]
26. Adenovirus-vectored foot-and-mouth disease vaccine confers early and full protection against FMDV O1 Manisa in swine.
Fernandez-Sainz I; Medina GN; Ramirez-Medina E; Koster MJ; Grubman MJ; de Los Santos T
Virology; 2017 Feb; 502():123-132. PubMed ID: 28039799
[TBL] [Abstract][Full Text] [Related]
27. An adenovirus vectored mucosal adjuvant augments protection of mice immunized intranasally with an adenovirus-vectored foot-and-mouth disease virus subunit vaccine.
Alejo DM; Moraes MP; Liao X; Dias CC; Tulman ER; Diaz-San Segundo F; Rood D; Grubman MJ; Silbart LK
Vaccine; 2013 Apr; 31(18):2302-9. PubMed ID: 23499593
[TBL] [Abstract][Full Text] [Related]
28. Phenotypic and functional characterization of T-cells and in vitro replication of FMDV serotypes in bovine lymphocytes.
Joshi G; Sharma R; Kakker NK
Vaccine; 2009 Nov; 27(48):6656-61. PubMed ID: 19751690
[TBL] [Abstract][Full Text] [Related]
29. HSV-1 amplicon vectors that direct the in situ production of foot-and-mouth disease virus antigens in mammalian cells can be used for genetic immunization.
D'Antuono A; Laimbacher AS; La Torre J; Tribulatti V; Romanutti C; Zamorano P; Quattrocchi V; Schraner EM; Ackermann M; Fraefel C; Mattion N
Vaccine; 2010 Oct; 28(46):7363-72. PubMed ID: 20851082
[TBL] [Abstract][Full Text] [Related]
30. Production and application of recombinant antibodies to foot-and-mouth disease virus non-structural protein 3ABC.
Foord AJ; Muller JD; Yu M; Wang LF; Heine HG
J Immunol Methods; 2007 Apr; 321(1-2):142-51. PubMed ID: 17328909
[TBL] [Abstract][Full Text] [Related]
31. Orally delivered foot-and-mouth disease virus capsid protomer vaccine displayed on T4 bacteriophage surface: 100% protection from potency challenge in mice.
Ren ZJ; Tian CJ; Zhu QS; Zhao MY; Xin AG; Nie WX; Ling SR; Zhu MW; Wu JY; Lan HY; Cao YC; Bi YZ
Vaccine; 2008 Mar; 26(11):1471-81. PubMed ID: 18289743
[TBL] [Abstract][Full Text] [Related]
32. Evidence of partial protection against foot-and-mouth disease in cattle immunized with a recombinant adenovirus vector expressing the precursor polypeptide (P1) of foot-and-mouth disease virus capsid proteins.
Sanz-Parra A; V Zquez B; Sobrino F; Cox SJ; Ley V; Salt JS
J Gen Virol; 1999 Mar; 80 ( Pt 3)():671-679. PubMed ID: 10092007
[TBL] [Abstract][Full Text] [Related]
33. DNA vaccines expressing B and T cell epitopes can protect mice from FMDV infection in the absence of specific humoral responses.
Borrego B; Fernandez-Pacheco P; Ganges L; Domenech N; Fernandez-Borges N; Sobrino F; Rodríguez F
Vaccine; 2006 May; 24(18):3889-99. PubMed ID: 16563575
[TBL] [Abstract][Full Text] [Related]
34. Development of foot-and-mouth disease virus (FMDV) serotype O virus-like-particles (VLPs) vaccine and evaluation of its potency.
Mohana Subramanian B; Madhanmohan M; Sriraman R; Chandrasekhar Reddy RV; Yuvaraj S; Manikumar K; Rajalakshmi S; Nagendrakumar SB; Rana SK; Srinivasan VA
Antiviral Res; 2012 Dec; 96(3):288-95. PubMed ID: 23043941
[TBL] [Abstract][Full Text] [Related]
35. Multiple efficacy studies of an adenovirus-vectored foot-and-mouth disease virus serotype A24 subunit vaccine in cattle using homologous challenge.
Schutta C; Barrera J; Pisano M; Zsak L; Grubman MJ; Mayr GA; Moraes MP; Kamicker BJ; Brake DA; Ettyreddy D; Brough DE; Butman BT; Neilan JG
Vaccine; 2016 Jun; 34(27):3214-3220. PubMed ID: 26707216
[TBL] [Abstract][Full Text] [Related]
36. Detection of foot-and-mouth disease virus infection in vaccinated cattle.
Niedbalski W
Pol J Vet Sci; 2005; 8(4):283-7. PubMed ID: 16385852
[TBL] [Abstract][Full Text] [Related]
37. Poly ICLC increases the potency of a replication-defective human adenovirus vectored foot-and-mouth disease vaccine.
Diaz-San Segundo F; Dias CC; Moraes MP; Weiss M; Perez-Martin E; Salazar AM; Grubman MJ; de Los Santos T
Virology; 2014 Nov; 468-470():283-292. PubMed ID: 25216089
[TBL] [Abstract][Full Text] [Related]
38. Adenovirus-mediated type I interferon expression delays and reduces disease signs in cattle challenged with foot-and-mouth disease virus.
Wu Q; Brum MC; Caron L; Koster M; Grubman MJ
J Interferon Cytokine Res; 2003 Jul; 23(7):359-68. PubMed ID: 14511462
[TBL] [Abstract][Full Text] [Related]
39. Chimeric foot-and-mouth disease viruses: evaluation of their efficacy as potential marker vaccines in cattle.
Fowler VL; Paton DJ; Rieder E; Barnett PV
Vaccine; 2008 Apr; 26(16):1982-9. PubMed ID: 18342409
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of modified Vaccinia Ankara-based vaccines against foot-and-mouth disease serotype A24 in cattle.
Steigerwald R; Brake DA; Barrera J; Schutta CJ; Kalla M; Wennier ST; Volkmann A; Hurtle W; Clark BA; Zurita M; Pisano M; Kamicker BJ; Puckette MC; Rasmussen MV; Neilan JG
Vaccine; 2020 Jan; 38(4):769-778. PubMed ID: 31718901
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
